RondinX is building a target and drug discovery platform designed to create solutions in the microbiome therapeutic and companion diagnostic spaces. RondinX's core technology is a peak-to-trough family of algorithms exclusively licensed from YEDA, the commercial arm of the Weizmann Institute of Science. The proprietary, cloud-based computational pipeline uses raw metagenomics to derive both static and dynamic strain-level insights into the bacterial ecosystem.